Trojan Energy
Trojan Energy’s mission is to make electric vehicle (EV) charging available to everyone, ensuring a fair price and efficient, convenient charging infrastructure for those without a driveway while also eliminating clutter on the pavement.
The Aberdeen-based company is aiming to be the UK’s solution of choice by 2023, enabling the low carbon transition.
Trojan Energy’s technology is a patent-protected ‘Flat and Flush’ pavement connection for EV charging. The product takes up less pavement space than bulkier alternatives, meaning more can be installed in busy urban areas. Users simply need to carry a charging ‘lance’, which then plugs into a socket-like point embedded in the pavement.
With 80-90% of EV charging taking place at home, the company aims to remove some of the infrastructure barriers to the adoption of EVs, especially in cities. Trojan Energy says its style of charge point will make it easier for the estimated 10 million people in the UK who don’t have off-street parking to own an EV.
The founding team are passionate about using their expertise to support the energy transition to net zero. Impressed by the founders’ passion and the product’s impact potential, SIS Ventures was delighted to
invest nearly £125,000 as part of a £4.1 million funding round led by Equity Gap in 2020. The investment is focused on strengthening the technology and ensuring the right team is in place to scale this opportunity
and create significant environmental impact.
Now with the delivery of its first trial and another funding round of £2.2 million announced in August 2021, Trojan Energy is progressing at pace.
With further plans to install more charge points across the UK and deliver volume manufacturing and longer-term plans to export to Europe, India and China, Trojan Energy is well on its way to supporting a significant reduction in carbon emissions.
Related news
Beta Bugs secures £1.72m to scale up sustainable insect farming
Read more about Beta Bugs secures £1.72m to scale up sustainable insect farmingMicroplate Dx secures £2.5m to develop rapid antibiotic testing technology
Read more about Microplate Dx secures £2.5m to develop rapid antibiotic testing technology